<DOC>
	<DOCNO>NCT00646529</DOCNO>
	<brief_summary>The purpose study assess safety Symbicort compare Pulmicort asthmatic child age 6 11 year</brief_summary>
	<brief_title>Long-Term Safety Symbicort Asthmatic Children - SAPLING</brief_title>
	<detailed_description />
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>At least 6 maximally 11 year age Diagnosis asthma Baseline lung function test determine protocol require receive daily treatment inhaled corticosteroid least 4 week prior study start Has require treatment noninhaled corticosteroid within previous 4 week , sensitivity drug specify protocol require treatment betablockers Has cancer previous 5 year significant disease may put patient risk study</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>asthma</keyword>
	<keyword>child</keyword>
	<keyword>Symbicort</keyword>
	<keyword>budesonide/formoterol</keyword>
	<keyword>Pulmicort</keyword>
	<keyword>budesonide</keyword>
</DOC>